87
55
Growth Score 87 in past quarter
-4 pts
Heat Score 55 in past quarter
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
300646
Intelligent Drug Design
- David Brooks: Product and Operations Manager
- Andrew Murphy: CTOPast Role: Life Whisperer, Chief Technology Officer
About the Company
Qubigen specializes in intelligent drug design by integrating Federated AI technology, quantum chemistry, and advanced machine learning methods. Qubigen's mission is to create the largest global federated proprietary dataset and computational toolbox for AI-driven drug design, enabling multiple entities such as pharmaceutical and biotech
companies to collaborate on new molecule discoveries simultaneously, thereby shortening drug development pipelines